These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1834187)

  • 21. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe Guillain-Barré syndrome in aged patients: the effect of plasmapheresis.
    Yamashita S; Morinaga T; Matsumoto K; Sakamoto T; Kaku N; Matsukura S
    Intern Med; 1992 Nov; 31(11):1313-6. PubMed ID: 1295631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute Guillain-Barré-like polyradiculoneuritis revealing acute systemic lupus erythematosus: two case studies and review of the literature].
    Aït Benhaddou E; Birouk N; El Alaoui-Faris M; Mzalek-Tazi Z; Aïdi S; Belaïdi H; Kably B; Ouazzani R; Chkili T
    Rev Neurol (Paris); 2003 Mar; 159(3):300-6. PubMed ID: 12703046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical course and treatment of acute inflammatory demyelinating polyradiculoneuropathy (Landry-Guillain-Barré syndrome)].
    Mozolevskiĭ IuV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):6-9. PubMed ID: 1326178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic inflammatory demyelinating polyradiculoneuropathy of acute onset: relapse after temporary improvement by plasma exchange and longstanding remission by corticosteroid therapy].
    Iwatsubo T; Sakanaka C; Obi T; Takeda K; Sakuta M
    Rinsho Shinkeigaku; 1989 Jul; 29(7):930-2. PubMed ID: 2805518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effects of plasmapheresis in acute Guillain-Barré syndrome.
    Piccolo G; Cosi V; Lombardi M; Poloni M; Ceroni M; Fornasari PM
    Ital J Neurol Sci; 1986 Jun; 7(3):349-52. PubMed ID: 3733414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of Guillain-Barré syndrome].
    Zagar M
    Lijec Vjesn; 1995; 117(9-10):246-9. PubMed ID: 8643018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Guillain-Barré syndrome: clinical features, immune mechanisms, and therapies].
    Nomura K
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1367-9. PubMed ID: 9128414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kappa/lambda ratios of IgG, IgA and IgM in the cerebrospinal fluid of patients with Guillain-Barré syndrome.
    Araga S; Kagimoto H; Adachi A; Funamoto K; Inoue K; Takahashi K
    Jpn J Med; 1991; 30(2):118-22. PubMed ID: 1907691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormalities of cerebrospinal fluid amino acids in patients with the Guillain-Barré syndrome.
    Corston RN; McGale EH; Stonier C; Aber GM; Hutchinson EC
    J Neurol Neurosurg Psychiatry; 1981 Jan; 44(1):86-9. PubMed ID: 7205311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of early beneficial response to plasma exchange in Guillain-Barré syndrome.
    Gruener G; Bosch EP; Strauss RG; Klugman M; Kimura J
    Arch Neurol; 1987 Mar; 44(3):295-8. PubMed ID: 3827680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmapheresis in the treatment of the Guillain-Barré syndrome in childhood.
    Yoshioka M; Kuroki S; Mizue H
    Pediatr Neurol; 1985; 1(6):329-34. PubMed ID: 2854736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.
    Rudnicki S; Vriesendorp F; Koski CL; Mayer RF
    Muscle Nerve; 1992 Jan; 15(1):57-62. PubMed ID: 1732763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré syndrome in children.
    Jones HR
    Curr Opin Pediatr; 1995 Dec; 7(6):663-8. PubMed ID: 8776016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Apheresis therapy in Guillain-Barré syndrome].
    Nagayama H; Katayama Y
    Nihon Rinsho; 2008 Jun; 66(6):1195-9. PubMed ID: 18540370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré syndrome.
    Ropper AH; Wijdicks EF; Shahani BT
    Arch Neurol; 1990 Aug; 47(8):881-7. PubMed ID: 2375695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group.
    Visser LH; van der Meché FG; Meulstee J; Rothbarth PP; Jacobs BC; Schmitz PI; van Doorn PA
    Neurology; 1996 Sep; 47(3):668-73. PubMed ID: 8797462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
    J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.
    Neurology; 1985 Aug; 35(8):1096-104. PubMed ID: 4022342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
    van der Meché FG; van Doorn PA
    Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.